Capsugel and Pulmatrix Partnering to Develop Inhaled Therapeutics for Range of Lung Diseases
COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News
Capsugel and Pulmatrix, Inc., entered a partnership to advance the development and manufacture of inhaled therapeutics to treat serious pulmonary diseases, based on Pulmatrix’s iSPERSE technology. “This collaboration provides us with ... Read more